ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,299,811 | +156.3% | 344,364 | +103.2% | 0.16% | +171.7% |
| Q2 2023 | $66,047,586 | +33.6% | 169,470 | +27.8% | 0.06% | +27.7% |
| Q1 2023 | $49,420,502 | -8.3% | 132,644 | -6.7% | 0.05% | -11.3% |
| Q4 2022 | $53,865,459 | -6.7% | 142,189 | -13.0% | 0.05% | -8.6% |
| Q3 2022 | $57,730,000 | -7.7% | 163,519 | -0.9% | 0.06% | 0.0% |
| Q2 2022 | $62,548,000 | -11.6% | 165,086 | -26.5% | 0.06% | +9.4% |
| Q1 2022 | $70,788,000 | -9.7% | 224,504 | +0.2% | 0.05% | 0.0% |
| Q4 2021 | $78,434,000 | -8.4% | 223,975 | -21.0% | 0.05% | -13.1% |
| Q3 2021 | $85,583,000 | +14.8% | 283,387 | +14.4% | 0.06% | +17.3% |
| Q2 2021 | $74,575,000 | +44.7% | 247,699 | +32.3% | 0.05% | +36.8% |
| Q1 2021 | $51,548,000 | – | 187,180 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |